CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 36 enrolled
Drug / intervention
Diagnostic P-V-loops and MRIother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02459626
NCT02459626N/ACompleted
CompareCT.gov

Comparison of Non-invasive Assessment of Cardiac Fibrosis by MRI Derived T1-Mapping and Ventricular Intrinsic Diastolic Function by Pressure-volume-analysis in Patients With Heart Failure With Preserved Ejection Fraction

Heart Center Leipzig - University Hospital·observational·Posted Jun 2, 2015·Updated May 10, 2021

In Brief

An observational study evaluating Diagnostic P-V-loops and MRI for Heart Failure With Normal Ejection Fraction. Completed, enrolled 36 participants across 1 site.

Detailed Summary

StiffMAP-HFpEF trial is an investigator initiated, observational, single-center study that will evaluate whether fibrosis quantification by cardiac MRI correlates with left and right ventricular stiffness derived from pressure-volume analysis, aiming to clarify if cardiac MRI is a valid, non-invasive method to assess diastolic function in patients with Heart Failure with preserved ejection fraction.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure With Normal Ejection Fraction
CountriesGermany
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJun 2, 2015
Enrollment StartSep 1, 2014
Primary CompletionMay 1, 2016
Study CompletionDec 1, 2018
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 11.1 years ago

Interventions

Diagnostic P-V-loops and MRIother

Invasive assessment of P-V-loops during catheterization for suspected CAD Magnetic resonance Imaging for assessment of myocardial fibrosis and biventricular function